NYSEARCA:EQOP Natixis U.S. Equity Opportunities ETF (EQOP) Price, Holdings, & News $28.93 -3.09 (-9.65%) (As of 07/18/2023) Add Compare Share Share Stock Analysis Stock Analysis About Natixis U.S. Equity Opportunities ETF (NYSEARCA:EQOP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get EQOP alerts:Sign Up Key Stats Today's Range$28.78▼$29.0050-Day Range$28.93▼$28.9352-Week Range$23.89▼$32.28Volume700 shsAverage Volume1,633 shsMarket Capitalization$9.26 millionAssets Under Management$9.34 millionDividend Yield7.09%Net Expense Ratio0.90%Aggregate RatingModerate Buy ETF OverviewThe Natixis U.S. Equity Opportunities ETF (EQOP) is an exchange-traded fund that is based on the S&P 500 index. The fund is an actively managed, non-transparent ETF to provide exposure to broad US equity market. Stock selections are made by two portfolio managers EQOP was launched on Sep 17, 2020 and is managed by Natixis.Read More… We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Natixis U.S. Equity Opportunities ETF ExpensesTypeEQOPNYSEARCA ETFsAll ETFsManagement Fee0.75%0.51%0.52%Other Expenses0.82%0.58%0.53%Total Expense1.57%0.73%0.71%Fee Waiver-0.67%-0.68%-0.57%Net Expense0.90%0.58%0.59% Receive EQOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Natixis U.S. Equity Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address EQOP ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com EQOP ETF - Frequently Asked Questions How have EQOP shares performed this year? Natixis U.S. Equity Opportunities ETF's stock was trading at $28.93 at the beginning of the year. Since then, EQOP stock has increased by 0.0% and is now trading at $28.93. View the best growth stocks for 2024 here. How do I buy shares of Natixis U.S. Equity Opportunities ETF? Shares of EQOP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Fund Details Issuer Fund NameNATIXIS U.S. EQU OPP ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:EQOP Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings95 Fund Statistics Assets Under Management$9.34 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares320,000Beta1.04 Creation Unit10,000 Creation Fee$200.00 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Top 10 EQOP HoldingsMeta Platforms (NASDAQ:META)Holding Weight: 5.06%Alphabet (NASDAQ:GOOGL)Holding Weight: 4.41%Amazon.com (NASDAQ:AMZN)Holding Weight: 4.21%Oracle (NYSE:ORCL)Holding Weight: 4.21%Salesforce (NYSE:CRM)Holding Weight: 3.15%NVIDIA (NASDAQ:NVDA)Holding Weight: 3.11%Netflix (NASDAQ:NFLX)Holding Weight: 2.92%KKR & Co. Inc. (NYSE:KKR)Holding Weight: 2.79%Workday (NASDAQ:WDAY)Holding Weight: 2.73%Fixed Inc Clearing Corp.RepoHolding Weight: 2.55%Full Holdings Details This page (NYSEARCA:EQOP) was last updated on 10/30/2024 by MarketBeat.com Staff From Our Partners625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredThis biotech's ONE drug could change medicine as we know itThis Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses...Smallcaps Daily | Sponsored2 Pro Traders… 4 Livestreams… 4 Live TradesThe Zero Day Loophole: The Secret of HUGE Overnight Profits from Government ReportsMonument Traders Alliance | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredIs your portfolio prepared for AI 2.0?AI has exploded ever since ChatGPT set the world on fire near the end of 2022. Numerous companies with conn...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natixis U.S. Equity Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Natixis U.S. Equity Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.